Policy Views

Discover our articles

Posted on 23.06.2025

IVDR reforms: an opportunity to create a system fit for the future

By Anna Hallersten, Head Regulatory Policy Europe, Roche Diagnostics

Posted on 19.05.2025

A golden age of ageing: how Europe can outpace its growing healthcare needs

By Gavin Wood, Company Group Chairman, Johnson & Johnson MedTech EMEA

Posted on 08.05.2025

Patients and doctors express confidence in the medtech revolution

By Julia Fishman, Head of Digital Solutions, Johnson & Johnson MedTech EMEA

Posted on 05.05.2025

Will the EU Health Technology Assessment Regulation boost medtech innovation?

By Andrea Rappagliosi, Senior Vice President Public Affairs EMECLA, Edwards Lifesciences

Posted on 29.04.2025

Wanted: clear assessment criteria for digital health technologies

By Katarzyna Markiewicz-Barreaux, AI Strategic Intelligence Lead, Philips

Posted on 10.01.2025

MDR/IVDR Article 10a – A new bureaucratic challenge for manufacturers you may have missed

By Frank Matzek, Vice President Regulatory & Governmental Affairs, BIOTRONIK

Posted on 07.01.2025

Third-party litigation in Europe: could it fuel a US-style class action culture?

By Pablo Rojas Abad, Senior Legal Counsel, MedTech Europe

Posted on 21.11.2024

Why now is the time to talk about procurement in the medical technology sector

981_3053

By Hans Bax, Senior Advisor Value & Innovation-based Access

Posted on 08.11.2024

Can Europe unlock the power of data while protecting privacy?

By Renate van Kempen, Data Anonymisation Expert  and Data Scientist

Posted on 07.11.2024

Beyond the checkbox: My views on compliance

By Samih Al Mawass, Abbott, Divisional Vice President, Abbott Vascular for Europe, Middle East and Africa

Posted on 06.11.2024

The landmark AI Act, its ripple effects on the medical technology industry and the challenges yet to be tackled

By Alexander Olbrechts, Director Digital Health, MedTech Europe

Posted on 12.10.2024

From burden to breakthrough: Orthopaedic innovations for osteoarthritis care

By Andrew Dalton, EMEA Vice President, Johnson & Johnson MedTech, Orthopaedics

Have a view ?
We want to hear from you